Chronic urticaria represents a cutaneous reaction pattern that may las
t for slightly more than six weeks to more than five years. Treatment
of patients with chronic urticaria can be a problem for both physician
and patient because of the significant side effects that may be cause
d by first-generation H-1 antihistamines or long-term corticosteroid t
herapy. Newer antihistamines represent a major advance for the treatme
nt of patients with chronic urticaria. Of this group, cetirizine appea
rs to offer some distinct pharmacokinetic and pharmacodynamic advantag
es. An open-label multicenter trial of 217 patients with chronic idiop
athic urticaria demonstrated that cetirizine was effective, rapid in o
nset, and well tolerated. Thus, cetirizine was shown to be an attracti
ve alternative treatment for patients with chronic idiopathic urticari
a.